Lantheus Holdings LNTH
NASDAQ LNTH
$100.32 -0.16 (-0.16%)
As of: Aug 20, 2026 · 3:56 PM EDT

Lantheus Holdings (LNTH) Other Operating Expenses (2014 - 2026)

Lantheus Holdings (LNTH) posted quarterly Other Operating Expenses of $59.3 million for Q1 2026, up 2645.4% quarter-over-quarter from $2.2 million in Q4 2024.

Lantheus Holdings (LNTH) Other Operating Expenses (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Other Operating Expenses for 6 consecutive years, with $59.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Operating Expenses changed N/A year-over-year to $59.3 million; the TTM figure through Mar 2026 stood at $59.3 million (up 2645.4% YoY), while the FY2024 annual figure was $8.4 million, changed N/A from the prior year.
  • Other Operating Expenses improved to $59.3 million in Q1 2026 per LNTH's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $59.3 million in Q1 2026 and bottomed at $2.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Lantheus Holdings 6.54 Bn 5.94 Bn 241.86 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 199,000.00
Mar 31, 2026 59.33 Mn
Dec 31, 2024 2.16 Mn
Mar 31, 2024 6.25 Mn
Mar 31, 2021 15.26 Mn
Dec 31, 2016 -120,000.00
Sep 30, 2016 560,000.00
Jun 30, 2016 117,000.00
Mar 31, 2016 5.83 Mn
Dec 31, 2015 -12.58 Mn
Sep 30, 2015 2.46 Mn
Jun 30, 2015 2.64 Mn
Mar 31, 2015 6.20 Mn
Dec 31, 2014 4.72 Mn
Sep 30, 2014 3.05 Mn
Jun 30, 2014 2.69 Mn